NCT04430777View on ClinicalTrials.gov

Use of Tranexamic Acid in Liposculpture

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

February 22, 2020

Study Completion Date

February 22, 2020

Conditions
Blood Loss, Surgical
Interventions
DRUG

Tranexamic acid

Administration of tranexamic acid 1 gr either intravenously or subcutaneously

Trial Locations (3)

Unknown

Dhara clinic, Bogotá

Innovare hospital, Jalisco

Centro Medico de las Americas clinic, Mérida

All Listed Sponsors
lead

Total Definer Research Group

OTHER

NCT04430777 - Use of Tranexamic Acid in Liposculpture | Biotech Hunter | Biotech Hunter